Josh Huang receives NIH Pioneer Award

Wednesday, October 6, 2021
josh huang headshot

The National Institutes of Health (NIH) has awarded grants to three Duke University School of Medicine faculty members through the NIH Common Fund’s High-Risk, High-Reward Research program. The research of Josh Huang, PhD; Tiarney Ritchwood, PhD; and Clare Smith, PhD, will be supported through the program, which funds highly innovative and broadly impactful biomedical or behavioral research by exceptionally creative scientists. The NIH awarded 106 grants totaling approximately $329 million over five years, pending availability of funds.

The High-Risk, High-Reward Research program catalyzes scientific discovery by supporting highly innovative research proposals that, due to their inherent risk, may struggle in the traditional peer-review process despite their transformative potential. Program applicants are encouraged to think “outside the box” and pursue trailblazing ideas in any area of research relevant to the NIH’s mission to advance knowledge and enhance health.

“The science put forward by this cohort is exceptionally novel and creative and is sure to push at the boundaries of what is known,” said NIH Director Francis S. Collins, MD, PhD. “These visionary investigators come from a wide breadth of career stages and show that groundbreaking science can happen at any career level given the right opportunity.” 

The High-Risk, High-Reward Research Program is part of the NIH Common Fund, which oversees programs that pursue major opportunities and gaps throughout the research enterprise that are of great importance to NIH and require collaboration across the agency to succeed. The High-Risk, High-Reward Research program manages four awards: the NIH Director’s Pioneer Award, the NIH Director’s New Innovator Award, the NIH Director’s Transformative Research Award, and the NIH Director’s Early Independence Award. 

Huang, a professor of neurobiology, received a Pioneer Award. He is developing a new generation of precise and programmable cell engineering technologies to monitor and edit the function of diverse cell types across animal organs and species, with potentially broad applications in biomedical research, biotechnology, and therapeutics. 

Established in 2004, the Pioneer Award challenges investigators at all career levels to pursue new research directions and develop groundbreaking, high-impact approaches to a broad area of biomedical, behavioral, or social science. The Pioneer Award provides $700,000 in direct costs per year for up to five years.

Full story in Duke School of Medicine blog